Adam H. Zaeske - 22 Jan 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: CHIEF COMMERCIAL OFFICER
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol: HRMY
Transactions as of: 22 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 26 Jan 2026, 16:44:30 UTC
Previous filing: 16 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Zaeske Adam H.	CHIEF COMMERCIAL OFFICER	C/O HARMONY BIOSCIENCES HOLDINGS, INC., PLYMOUTH MEETING	/s/ Christian Ulrich, Attorney-in-Fact	26 Jan 2026	0002064712

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Stock Option	Award	$0	+56,900		$0.000000	56,900	22 Jan 2026	Common Stock	56,900	$36.76	Direct	F1
transaction	HRMY	Restricted Stock Units	Award	$0	+16,200		$0.000000	16,200	22 Jan 2026	Common Stock	16,200		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
F2	The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.